Capula Management’s Amicus Therapeutics FOLD Stock Holding History

Capula Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,191,610	Closed	-$46.2M	–	875
2026 Q1	$46.2M	Buy	3,191,610 +3,161,610	+10,539%	+$45.3M	0.33%	18
2025 Q4	$427K	Buy	+30,000	New	+$295K	﹤0.01%	417
2024 Q2	–	Sell	-17,000	Closed	-$200K	–	512
2024 Q1	$200K	Buy	+17,000	New	+$217K	﹤0.01%	409
2021 Q4	–	Sell	-11,705	Closed	-$112K	–	415
2021 Q3	$112K	Buy	+11,705	New	+$120K	﹤0.01%	818

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Capula Management's FOLD Position: Q2 2026 in Review

Capula Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 3,191,610 shares — an estimated $46.2M sold.

Capula Management first reported a position in FOLD in Q3 2021 and held it in 4 quarters. The position peaked at $46.2M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Capula Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Capula Management sold 3,191,610 Amicus Therapeutics shares in Q2 2026, an estimated $46.2M.
Capula Management first reported a position in Amicus Therapeutics in Q3 2021 and held it in 4 quarters.
Capula Management's Amicus Therapeutics position peaked at $46.2M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.